Recursos

OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings.

Related Articles OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings. Int J Mol Sci. 2017 Mar 27;18(4): Authors: Hajj A, Halepian L, Osta NE, Chahine G, Kattan J, Rabbaa Khabbaz L Abstract Despite increased attention on assessment and management, pain remains the most persistent symptom in patients with cancer, in particular in end-of-life settings, with detrimental impact on their quality-of-life (QOL). We conducted this study to evaluate the added value of determining some genetic and non-genetic factors to optimize cancer pain treatment. Eighty-nine patients were included in the study…
Origen: OPRM1 c.118A>G Polymorphism and Duration of Morphine Treatment Associated with Morphine Doses and Quality-of-Life in Palliative Cancer Pain Settings. – PubMed

Leer más Sin comentarios

Recursos

Drill-assisted, fluoroscopy-guided vertebral body access for radiofrequency ablation: Technical case series.

Related Articles Drill-assisted, fluoroscopy-guided vertebral body access for radiofrequency ablation: Technical case series. Interv Neuroradiol. 2015 Oct;21(5):631-4 Authors: Wallace AN, Chang RO, Tomasian A, Jennings JW Abstract Radiofrequency ablation is a valuable therapy for palliation of painful spinal metastases and local tumor control; however, accessing the vertebral body can be difficult and time consuming with traditional manual needles. Herein, we report our initial experience using a drill-assisted, fluoroscopy-guided technique for accessing the vertebral body for radiofrequency ablation. PMID: 26179064 [PubMed – indexed for MEDLINE]
Origen: Drill-assisted, fluoroscopy-guided vertebral body access for radiofrequency ablation: Technical case series. – PubMed

Leer más Sin comentarios

Recursos

Improving palliative care in selected settings in England using quality indicators: a realist evaluation.

Related Articles Improving palliative care in selected settings in England using quality indicators: a realist evaluation. BMC Palliat Care. 2016 Aug 02;15:69 Authors: Iliffe S, Davies N, Manthorpe J, Crome P, Ahmedzai SH, Vernooij-Dassen M, Engels Y Abstract BACKGROUND: There is a gap between readily available evidence of best practice and its use in everyday palliative care. The IMPACT study evaluated the potential of facilitated use of Quality Indicators as tools to improve palliative care in different settings in England. METHODS: 1) Modelling palliative care services and selecting a set of Quality Indicators to form the core of an intervention,…
Origen: Improving palliative care in selected settings in England using quality indicators: a realist evaluation. – PubMed

Leer más Sin comentarios

Recursos

Svenska palliativregistret visar kvaliteten på vård vid livets slut – Ger stöd och hjälp åt vårdenheter för kontinuerligt förbättringsarbete.

Related Articles Svenska palliativregistret visar kvaliteten på vård vid livets slut – Ger stöd och hjälp åt vårdenheter för kontinuerligt förbättringsarbete. Lakartidningen. 2016 Nov 22;113: Authors: Axelsson B, Lundorff L, Fransson G PMID: 27898138 [PubMed – indexed for MEDLINE]
Origen: Svenska palliativregistret visar kvaliteten på vård vid livets slut – Ger stöd och hjälp åt vårdenheter för kontinuerligt förbättringsarbete. – PubMed

Leer más Sin comentarios

Recursos

Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy.

Related Articles Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy. Medicine (Baltimore). 2017 May;96(19):e6848 Authors: Koh YW, Lee HW Abstract Recent studies have indicated that the C-reactive protein (CRP)/albumin (CRP/Alb) ratio is associated with clinical outcomes in patients with various carcinomas. However, no studies have explored the association between the ratio of CRP/Alb and clinical outcome of inoperable patients with nonsmall cell lung cancers (NSCLCs). We examined the prognostic impact of CRP/Alb ratio on 165 stage IV NSCLC receiving palliative chemotherapy. The optimal cutoff level of CRP/Alb…
Origen: Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy. – PubMed

Leer más Sin comentarios

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

ACEPTAR
Aviso de cookies